GlassScriptPhysician profile
Sammy Sinno
NPI 1174814412
$5,090.96
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,325 · 2020: $259 · 2021: $80.56 · 2022: $553 · 2023: $383 · 2024: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Travel and Lodging: $13.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.45 |
| Travel and Lodging | $13.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,037.38 | 2019-2022 | |
| Davol INC. | $606.76 | 2022-2024 | Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $499.47 | 2019-2024 | |
| Innovation Technologies INC | $167.57 | 2023 | Irrisept |
| Tela Bio, INC. | $150.52 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Avita Medical Americas, LLC | $143.11 | 2024 | |
| Osiris Therapeutics INC. | $122.04 | 2019 | |
| Integra Lifesciences Corporation | $113.39 | 2019 | |
| Tepha INC | $87.80 | 2019 | |
| Abbvie INC. | $51.48 | 2023 | Natrelle Saline-Filled Breast Implants |
| Merz North America, INC. | $49.57 | 2019 | |
| Galderma Laboratories, L.P. | $47.25 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $14.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sammy Sinno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.